Risk of Uncomplicated Peptic Ulcer among Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs

American Journal of Epidemiology

Volumn 159, Issue 1, 2004, Pages 23-31

  García Rodríguez, Luis Alberto ^a   Hernández Díaz, Sonia ^b  

^a Department of Pharmacoepidemiology   (Spain)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Anti inflammatory agents; Aspirin; Drug toxicity; Non steroidal; Peptic ulcer

Indexed keywords

ACECLOFENAC; ACEMETACIN; ACETYLSALICYLIC ACID; AZAPROPAZONE; CIMETIDINE; CORTICOSTEROID; DICLOFENAC; ETODOLAC; FAMOTIDINE; FENBUFEN; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; LANSOPRAZOLE; MEFENAMIC ACID; MELOXICAM; MISOPROSTOL; NABUMETONE; NAPROXEN; NIZATIDINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PARACETAMOL; PIROXICAM; SULINDAC; TENOXICAM; TIAPROFENIC ACID; UNINDEXED DRUG;

HEALTH RISK;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EXPOSURE; DUODENUM ULCER; FEMALE; FOLLOW UP; HELICOBACTER PYLORI; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRESCRIPTION; RISK ASSESSMENT; STOMACH ULCER; UNITED KINGDOM;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; COHORT STUDIES; DATABASES; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEPTIC ULCER; SEVERITY OF ILLNESS INDEX;

EID: 17644444813     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh005     Document Type: Article

References (30)

1. Guess H, West R, Strand L, et al. Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol 1988;41:35-45.
2. Smalley WE, Ray WA, Daugherty JR, et al. Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons. Am J Epidemiol 1995;141:539-45.
3. García Rodríguez LA, Cattaruzzi C, Troncon MG, et al. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998;158:33-9.
4. Hernández-Díaz S, García Rodríguez LA. Incidence of serious upper gastrointestinal bleeding/perforation in the general population: review of epidemiologic studies. J Clin Epidemiol 2002;55:157-63.
5. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology 1993;105:1078-88.
6. Hernández-Díaz S, García-Rodríguez LA. Overview of epidemiological studies published in the nineties on the association between non-steroidal anti-inflammatory drugs and upper gastrointestinal bleed/perforation. Arch Intern Med 2000;160:2093-9.
7. García Rodríguez LA, Hernández-Díaz S, De Abajo FJ. Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br J Clin Pharmacol 2001;52:563-71.
8. Bloom BS. Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs. Arch Intern Med 1989;149:1019-22.
9. Smalley WE, Griffin MR. The risks and costs of upper gastrointestinal disease attributable to NSAIDs. Gastroenterol Clin North Am 1996;25:373-96.
10. Armstrong CP, Blower A. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987;28:527-32.
11. Soll AH, Weinstein WM, Hurata J, et al. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 1991;114:307-19.
12. García Rodríguez LA, Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998;45:419-25.
13. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the General Practice Research Database. Pharmacotherapy 2003;23:686-9.
14. Jick H, Jick SS, Dervy LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
15. García Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:769-72.
16. Garcia Rodriguez LA, Hernández-Díaz S. Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology 2001;12:570-6.
17. Walker AM. Observation and inference. An introduction to the methods of epidemiology. Newton Lower Falls, MA: Epidemiology Resources, Inc, 1991.
18. Simon LS, Weaver AL, Graham DY, et al. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis. A randomized trial. JAMA 1999;282:1921-8.
19. Langman MJ, Jensen DM, Watson DJ, et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999;282:1929-33.
20. Schoon IM, Mellstrom D, Oden A, et al. Incidence of peptic ulcer disease in Gothenburg, 1985. BMJ 1989;299:1131-4.
21. Bloom BS, Fendrick M, Ramsey SD. Changes in peptic ulcer and gastritis/duodenitis in Great Britain, 1970-1985. J Clin Gastroenterol 1990;12:100-8.
22. Rosenstock S, Jorgensen T. Prevalence and incidence of peptic ulcer disease in a Danish county - a prospective cohort study. Gut 1995;36:819-24.
23. MacDonald T, Morant S, Robinson G, et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study. BMJ 1997;315:1333-7.
24. Menniti-Ippolito F, Maggini M, Raschetti R, et al. Ketorolac use in outpatients and gastrointestinal hospitalization: a comparison with other non-steroidal anti-inflammatory drugs in Italy. Eur J Clin Pharmacol 1998;54:393-7.
25. Kang JY, Tinto A, Higham J, et al. Peptic ulceration in general practice in England and Wales 1994-98: period prevalence and drug management. Aliment Pharmacol Ther 2002;16:1067-74.
26. Mcintosh J, Byth K, Piper DW. Environmental factors in aetiology of chronic gastric ulcer: a case control study of exposure variables before the first symptoms. Gut 1985;26:789-98.
27. Duggan J, Dobson A, Johnson H. Peptic ulcer and non-steroidal anti-inflammatory agents. Gut 1986;27:929-33.
28. Traversa G, Walker AM, Ippolito FM, et al. Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology 1995;6:49-54.
29. Laine L. Review article: the effect of Helicobacterpylori infection on nonsteroidal anti-inflammatory drug-induced upper gastrointestinal tract injury. Aliment Pharmacol Ther 2002;16(suppl):34-9.
30. Hawkey CJ, Karrasch JA, Szczepanski L, et al. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med 1998;338:727-34.